Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Submitted by
admin
on October 16, 2011 - 7:05pm
Source:
Seeking Alpha
News Tags:
Micromet
Pfizer
blinatumomab
acute lymphoblastic leukemia
leukemia
Bmab
SAR3419
Sanofi
inotuzumab
Genentech
Seattle Genetics
Headline:
Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor
Do Not Allow Advertisers to Use My Personal information
